Skip to main content
. 2008 Sep 11;3(9):e3193. doi: 10.1371/journal.pone.0003193

Figure 2. Effect of PEV with MSTBV (a,b,c) on infectivity to vector over 20 years when delivered via EPI (black), EPI with boosters (blue) and EPI with 95% mass vaccination (red) for transmissions settings of EIR 21 (a), 42 (b) and 168 (c).

Figure 2

Results obtained assuming a vaccine efficacy of 52%, half-life of 10 years and homogeneity value of 10.